(Q47965764)

English

Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat.

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat. (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

0 references

1 reference

based on heuristic

inferred from title

Stephen Spellman

2

object named as

Stephen R Spellman

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

author name string

Walter C Jean

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

Margaret A Wallenfriedman

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

Christine T Flores

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

Brian P Kurtz

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

Walter A Hall

6

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

Walter C Low

7

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

publication date

1 January 2004

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

66

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

1-2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

39-49

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

https://scigraph.springernature.com/pub.10.1023/b:neon.0000013477.94568.0f

0 references

Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Demonstration of a rational strategy for human prostate cancer gene therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-12-based immunotherapy against rat 9L glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by IL-12/pulse IL-2: induction of local T cell infiltration, Fas/Fas ligand gene expression, and mammary

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GM-CSF-based cellular vaccines: a review of the clinical experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell subpopulations dispersed from solid tumours and separated by centrifugal elutriation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-tumor activity of interleukin-2-producing tumor cells and recombinant interleukin 12 against mouse glioma cells located in the central nervous system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced immune priming with spatial distribution of paracrine cytokine vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte macrophage-colony stimulating factor gene transfer to induce a protective anti-tumoral immune response against the 9L rat gliosarcoma model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination for experimental gliomas using GM-CSF-transduced glioma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of antitumor immunity by intracerebrally implanted rat C6 glioma cells genetically engineered to secrete cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic and local paracrine cytokine therapies using transduced tumor cells are synergistic in treating intracranial tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of orthotopic brain tumors by cytokine-assisted tumor vaccines primed in the brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of T-cell function by gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor-alpha expression in ischemic neurons.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy using lymphokine-activated killer (LAK) cells and interleukin-2 for recurrent malignant primary brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic T cell adoptive immunotherapy of malignant gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of interleukin 12 against interleukin 2-transduced mouse glioma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells and the control of immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-12 as an adjuvant for cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic strategies for cytokines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15015768

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/B:NEON.0000013477.94568.0F

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/15015768

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47965764&oldid=1808567804"